Polycystic kidney disease (PKD), a family of genetic disorders that causes clusters of cysts to form on the kidney, is among the most common genetic disorders, affecting some 500,000 people in the ...

Surendra Kumar Sahoo was just 27 years old when he discovered that he was suffering from end-stage renal disease, which meant ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

Lenmed Ethekwini Hospital is revolutionising care for congenital kidney diseases, ensuring early detection and comprehensive ...

Tanzania is set to enhance specialised healthcare services as Bugando Medical Centre (BMC), a referral hospital in the Lake ...

High blood pressure strikes Black Americans earlier and more severely than other groups. Discover 6 strategies and ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Weight fluctuation was associated with a greater risk for diabetic kidney disease progression among individuals with type 1 diabetes.

For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Chronic kidney disease can be a silent killer; thus, we need to know about the causes and symptoms of CKD in advance for ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.